Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 71Sarcoma 12Brain Neoplasms 10Gliosarcoma 9Glioblastoma 9Neoplasm Metastasis 6Glioma 6Dermatofibrosarcoma 6Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Fibrosarcoma 4Chordoma 4Sarcoma, Synovial 3Osteosarcoma 3Neurofibrosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Glioma, Subependymal 3Digestive System Neoplasms 3Desmoid Tumors 3Sarcoma, Endometrial Stromal 2Recurrence 2Primary Myelofibrosis 2Piebaldism 2Multiple Myeloma 2Meningioma 2

Interventions

Doxorubicin 19Ifosfamide 12Radiotherapy 11pembrolizumab 6Nivolumab 6Ipilimumab 6pazopanib 4Specimen Handling 4Radiation 4Gemcitabine 4Docetaxel 4CTLA-4 Antigen 4Biopsy 4Trabectedin 3Sunitinib 3Magnetic Resonance Spectroscopy 3pegfilgrastim 2liposomal doxorubicin 2cabozantinib 2brostallicin 2X-Rays 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Methotrexate 2Imatinib Mesylate 2Filgrastim 2Etoposide 2Diathermy 2Cisplatin 2Chemotherapy, Adjuvant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Imatinib Mesylate × Sarcoma × Clear all
NCT00006357 2012-09-24

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
91 enrolled
GastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

NCT00085475 2012-09-24

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
17 enrolled
Sarcoma

Fibrosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡